SCHEMBL27433650

SCHEMBL27433650

CCOC(=O)c1c(O)ccc(Cl)c1F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.61
CA1 P00915 5/20 0.61
CA2 P00918 5/20 0.61
CA7 P43166 5/20 0.61
CA9 Q16790 5/20 0.61
CA14 Q9ULX7 5/20 0.61
NR1H2 P55055 1/20 0.54
NR1H3 Q13133 1/20 0.54
CYP3A4 P08684 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
ALOX5 P09917 4/20 0.43
PTGES O14684 1/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
HSD17B2 P37059 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30385269 1.00 CA12 (0.61) CA12CA1CA2CA7CA9
SCHEMBL20644257 0.82 CYP4F2 (0.47) CA12CA1CA2CA7CA9
SCHEMBL8278988 0.82 ALDH1A1 (0.46) CA12CA1CA2CA7CA9
SCHEMBL6643404 0.81 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL27433759 0.81 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL30954081 0.81 CA12 (0.57) CA12CA1CA2CA7CA9
SCHEMBL30954120 0.81 PRKCZ (0.46) CA12CA1CA2CA7CA9
SCHEMBL27433649 0.81 PRKCZ (0.46) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL4934877 0.81 ALDH1A1 (0.45) CA12CA1CA2CA7CA9
SCHEMBL1671329 0.80 CA12 (0.47) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed